The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Relative incidence of seizures and myoclonus in Alzheimer’s disease, dementia with lewy bodies, and frontotemporal dementia.
Open accessAbstract
BACKGROUND: Patients with Alzheimer's disease (AD) are more prone to seizures and myoclonus, but relative risk of these symptoms among other dementia types is unknown. OBJECTIVE: To determine incidence of seizures and myoclonus in the three most common neurodegenerative dementias: AD, dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD). METHODS: Our institution's medical records were reviewed for new-onset unprovoked seizures and myoclonus in patients meeting criteria for AD (n = 1,320), DLB (n = 178), and FTD (n = 348). Cumulative probabilities of developing seizures and myoclonus were compared between diagnostic groups, whereas age-stratified incidence rates were determined relative to control populations. RESULTS: The cumulative probability of developing seizures after disease onset was 11.5% overall, highest in AD (13.4%) and DLB (14.7%) and lowest in FTD (3.0%). The cumulative probability of developing myoclonus was 42.1% overall, highest in DLB (58.1%). The seizure incidence rates, relative to control populations, were nearly 10-fold in AD and DLB, and 6-fold in FTD. Relative seizure rates increased with earlier age-at-onset in AD (age <50, 127-fold; 50-69, 21-fold; 70+, 2-fold) and FTD (age <50, 53-fold; 50-69, 9-fold), and relative myoclonus rates increased with earlier age-at-onset in all groups. Seizures began an average of 3.9 years after the onset of cognitive or motor decline, and myoclonus began 5.4 years after onset. CONCLUSIONS: Seizures and myoclonus occur with greater incidence in patients with AD, DLB, and FTD than in the general population, but rates vary with diagnosis, suggesting varied pathomechanisms of network hyperexcitability. Patients often experience these symptoms early in disease, suggesting hyperexcitability could be an important target for interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the possibility of seizures and hyperexcitability in primary tauopathies should not be ruled out, as they occur more frequently in these diseases than in the general population (Beagle et al., 2017; Sanchez et al., 2018).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Beagle et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Seizures are more common in AD and dementia with Lewy bodies than in primary tauopathies, such as frontotemporal dementia and progressive supranuclear palsy (Beagle et al., 2017).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Beagle et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A mechanism by which epileptogenesis gives rise to tau hyperphosphorylation may underlie the high incidence of tauopathy and epilepsy co-pathology that is found in diseases such as AD and dementia with Lewy bodies (Vossel et al., 2016, 2017; Beagle et al., 2017).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Beagle et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Weıntraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 3,018
Appelhof, B., Bakker, C., den IJssel, J. C. L. V. D., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,774
Research works printed but not linked: 1
- Rothman, 2008, Modern Epidemiology
Cited by
Sorted by citations
Items 101–173 of 173
Parkinsonism in genetic and sporadic Alzheimer's disease
Levin, J. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.005 · Cited by 4
Seizures and Epilepsy in Dementia: Diagnosis and Management
Ritter, L. M., & Nilsson, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-77904-7_12 · Cited by 4
Is the pathology of posterior cortical atrophy clinically predictable?
Cipriano, L., Oliva, M., Puoti, G., Signoriello, E., Bonavita, S., & Coppola, C. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0003 · Cited by 4
Olkhova, E. A., Smith, L. A., Dennis, B. H., Ng, Y. S., LeBeau, F. E. N., & Gorman, G. S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230191 · Cited by 3
Dementia with Lewy bodies: a practical guide to clinical diagnosis and management
Fullam, S., Harrison, J. R., Anderson, K. N., Fearon, C., O’Connor, A., Taylor, J., & O’Dowd, S. (2025) · Practical Neurology · doi:10.1136/pn-2025-004745 · Cited by 3
Brigo, F., & Lattanzi, S. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2325038 · Cited by 3
Пизова, Н. В., & Pizov, A. V. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-10-86-93 · Cited by 3
Пізня епілепсія: особливості діагностики та лікування
Львівський національний медичний університет імені Данила Галицького, Л., Maryenko, L. B., Мар’єнко, К. М., & Львівський національний медичний університет імені Данила Галицького, Л. (2021) · Український медичний часопис · doi:10.32471/umj.1680-3051.141.199992 · Cited by 3
Cretin, B., & Blanc, F. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1707185 · Cited by 3
Multi-class Modeling Identifies Shared Genetic Risk for Late-onset Epilepsy and Alzheimer’s DiseasePreprint
Fu, M., Tran, T., Eskin, E., Lajonchere, C., Paşaniuc, B., Geschwind, D. H., Vossel, K. A., & Chang, T. S. (2024) · medRxiv · doi:10.1101/2024.02.05.24302353 · Cited by 3
Self-citationQuiles, L. E. P., Quintay, P. K. P. V., Espiritu, A. I., Mendoza, V., & Anlacan, V. M. M. (2025) · Epilepsia Open · doi:10.1002/epi4.70013 · Cited by 2
Bae, Y., Kang, C., Choi, U., Jung, H., & Lee, S. W. (2025) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaf047 · Cited by 2
d’Orsi, G., Claudio, M. T. D., Soccio, A. A., Palumbo, V., Ferro, C. P., Costantino, U., Latino, R. R., & Fogli, D. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1655455 · Cited by 2
Advancing Mental Health Equity in Epilepsy: Social Determinants of Health Across the Lifespan
Gopaul, M., Fox, J. E., Smith, A. W., Maturu, S., McInnis, R. P., Patel, P. S., Brothers, S. L., Duberstein, S., Woodward, J. J., Conner, K., et al. (2026) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597251406119 · Cited by 2
Tau pathology in epilepsy: emerging mechanisms and translational opportunities
Sen, A., Tai, X. Y., Galanopoulou, A. S., Thom, M., Aronica, E., Vivash, L. E., Hardmeier, M., Amos, A., Rüegg, S. J., Koepp, M. J., et al. (2026) · Brain · doi:10.1093/brain/awag108 · Cited by 2
Lipka, J., & Hoogenraad, C. (2019) · Neuron · doi:10.1016/j.neuron.2019.10.021 · Cited by 2
Aguzzoli, C. S., Battista, P., Hadad, R., Borges, Y. F. F., Schilling, L. P., & Miller, B. L. (2022) · Neurocase · doi:10.1080/13554794.2022.2135448 · Cited by 2
The Role of Tau Protein on Alzheimer’s Disease
Su, Y. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.6141 · Cited by 2
Physical comorbidities of dementia: Recognition and rehabilitation
Kurrle, S. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818685-5.00012-x · Cited by 2
Ätiologien der Altersepilepsien: Nicht nur vaskulär!
von Podewils, F. (2022) · Clinical Epileptology · doi:10.1007/s10309-022-00488-7 · Cited by 2
Non-Convulsive Status Epilepticus in Behavioral Variant Frontotemporal Dementia
Carbó, A. V., Gajate-García, V., Romeral, M., Gutiérrez‐Viedma, Á., Parejo‐Carbonell, B., Cabrera‐Martín, M. N., Matías‐Guiu, J., Matías‐Guiu, J. A., & García‐Morales, I. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200512 · Cited by 2
Neurological examination: what do psychiatrists need to know?
Larner, A. J., Welch, K. A., & Carson, A. J. (2020) · BJPsych Advances · doi:10.1192/bja.2020.83 · Cited by 2
Saint, M., Alakbarzade, V., & McLean, B. (2021) · Case Reports in Neurology · doi:10.1159/000513852 · Cited by 2
ALSUntangled 46: penicillin G/hydrocortisone
The ALSUntangled Group, & Bedlack, R. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1512704 · Cited by 2
Peña, A. B. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108989855.044 · Cited by 1
Late onset epilepsy and dementia with Lewy bodies: Underestimated association?
Porché, M., Dumurgier, J., Hourrègue, C., & Paquet, C. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251328613 · Cited by 1
Co-morbid seizures in frontotemporal dementia: What do they tell us?
Hashmi, S. A., Quigg, M., D’Abreu, A., Manning, C. A., Kapur, J., & Zawar, I. (2025) · Epilepsy Research · doi:10.1016/j.eplepsyres.2025.107640 · Cited by 1
Late-onset epilepsy as a prodromal symptom
Dupont, S. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.07.007 · Cited by 1
Singh, T., Bridgeman, E., Baker, A. J., Noblet, H. A., Yang, K. Y., Kang, S., Lim, K. H., Lee, S. S., Amundsen, N. M., Lee, Y., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107246 · Cited by 1
From comorbidity to continuum: Alzheimer’s disease and epilepsy are connected-now what?
Alves, S. S., Manzine, P. R., dos Santos, F. M., Migliaccio, M. M., Alves, L. D. C., da Silva-Júnior, R. M. P., Becerra-Hernández, L. V., González-Acosta, C. A., Buriticá, E., Cominetti, M. R., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106682 · Cited by 1
Fratto, E., Buonocore, J., Fortunato, F., Sammarra, I., Calomino, C., Vescio, B., Quattrone, A., Gambardella, A., & Quattrone, A. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261450962 · Cited by 1
Recent Hospitalization and Initiation of Antiepileptics Among Persons With Alzheimer’s Disease
Elo, J., Tolppanen, A., Koponen, M., Tiihonen, M., & Hartikainen, S. A. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.10.009 · Cited by 1
Prevalance of Non-Provoke Generalize Tonic-Clonic Seizure in Sporadic Alzheimer’s Disease
Varlıbaş, F., Domaç, F. M., Yüksel, G. A., Akhan, O., & Üçgül, E. E. (2024) · Journal of Epilepsy Research · doi:10.14581/jer.24012 · Cited by 1
SOP Somatische Diagnostik bei Demenz
Wietelmann, D. (2019) · PSYCH up2date · doi:10.1055/a-0857-7189 · Cited by 1
Glutamatergic dysfunction precedes neuron loss in cerebral organoids with MAPT mutationPreprint
Bowles, K. R., Silva, M., Whitney, K., Bertucci, T., Garza, J. C., Boles, N., Strang, K. H., Mahali, S. K., Marsh, J. A., Chen, C., et al. (2021) · bioRxiv · doi:10.1101/2021.02.03.429623 · Cited by 3
Chartampila, E., Elayouby, K. S., Leary, P., LaFrancois, J. J., Alcantara‐Gonzalez, D., Jain, S. S., Gerencer, K., Botterill, J. J., Ginsberg, S. D., & Scharfman, H. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.12.540428 · Cited by 1
Chartampila, E., Elayouby, K. S., Leary, P., LaFrancois, J. J., Alcantara‐Gonzalez, D., Jain, S. S., Gerencer, K., Botterill, J. J., Ginsberg, S. D., & Scharfman, H. E. (2024) · eLife · doi:10.7554/elife.89889.2 · Cited by 1
Haeren (2018) · doi:10.26481/dis.20181026rh
Epilepsy and other neurological disorders
Zaccara, G., Giorgi, F. S., & Giovannelli, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814877-8.00012-x
Frucht, S. J., & Termsarasab, P. (2020) · Springer eBooks · doi:10.1007/978-3-030-36975-0_5
SOP Somatische Diagnostik bei Demenz
Wietelmann, D. (2020) · Geriatrie up2date · doi:10.1055/a-1034-0991
Clinical Findings That Are Subtle
Josephs, K. A., Rodriguez‐Porcel, F. E., Shatz, R. S., Weintraub, D. A., & Espay, A. J. (2020)
Josephs, K. A., Rodriguez‐Porcel, F. E., Shatz, R. S., Weintraub, D. A., & Espay, A. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108355841.026
Epilessia negli anziani: epilessia e demenze
de Toffol, B. (2021) · EMC - Neurologia · doi:10.1016/s1634-7072(21)44998-6
Akamatsu, N. (2020) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.109.1533
(2021) · Elsevier eBooks · doi:10.1016/b978-0-323-88445-7.16001-4
Non‐Parkinsonian movement disorders in the elderly
Amlang, C. J., & Kompoliti, K. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch54
Riepe, M. W. (2022) · Geriatrie up2date · doi:10.1055/a-1821-7799
Paley, E. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19122-0.00002-9
Management of elderly-onset epilepsy: A narrative review
Kodama, S., Shirota, Y., Hamada, M., Watanabe, M., & Toda, T. (2023) · Epilepsy & Seizure · doi:10.3805/eands.15.104
Chartampila, E., Elayouby, K. S., Leary, P., LaFrancois, J. J., Alcantara‐Gonzalez, D., Jain, S. S., Gerencer, K., Botterill, J. J., Ginsberg, S. D., & Scharfman, H. E. (2024) · eLife · doi:10.7554/elife.89889.3
Clinical Diagnosis of Alzheimer’s Disease
Güleç, Z. E. K., & Bozluolçay, M. (2024) · doi:10.69860/nobel.9786053359166.5
Therapiekonzepte bei bestimmten Behandlungssituationen
Krämer, G., & Steinhoff, B. J. (2025) · Springer eBooks · doi:10.1007/978-3-662-67714-8_8
Dupont, S. (2020) · Elsevier eBooks · doi:10.1016/b978-2-294-76278-9.00006-0
Tanaka, E., Nihashi, T., Kato, T., Arahata, Y., Takeda, A., Sakurai, K., Yokoi, K., Iwata, K., Diers, K., Maeß, B., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251379466
Nakaya, A., Kato, K., Jin, K., Ohtomo, S., Nakasato, N., & Aoki, M. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110721
Sun, X., Wu, L., Orr, T. C., Heck, A., Young, K., Dunaway, N., Navarro, J. C., Beechem, J., & Orr, M. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.19.689127
Phenotypic variability in early-onset dementia segregating with a novel APP (p.I718M) variant
Johansson, C., Rodriguez‐Vieitez, E., Blūma, M., Nennesmo, I., Thonberg, H., Ullgren, A., Jelić, V., Zetterberg, H., Blennow, K., Nordberg, A. K., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01890-9
Epileptic seizures in patients with Alzheimer’s disease
Бурд, С. Г., Bogolepova, A. N., Лебедева, А. В., Rubleva, Y. V., Коваленко, Е. А., Makhnovich, E. V., Osinovskaya, N. A., Gileva, E. A., Pantina, N. V., Kovaleva, I. I., et al. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512511136
Musaeus, C. S., Kjær, T. W., Lindberg, U., Vestergaard, M. B., Bo, H., Larsson, W., Press, D. Z., Andersen, B. B., Høgh, P., Kidmose, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25596440
Myoclonus in geriatric dogs and its association with canine cognitive dysfunction: an online survey
Brühl, S. M., Volk, H. A., Rohn, K., & Meyerhoff, N. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1745264
A Rare Case of Levetiracetam-Induced Hemolytic Anemia
Cruz, P. G. D. R., Torres, D. M., & Gonzalez, K. A. G. (2026) · Cureus · doi:10.7759/cureus.105064
Epilepsy and EEG abnormalities in neurodegenerative dementias: toward a system epilepsy framework
Manganotti, P., Palacino, F., Pavan, S., & Benussi, A. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1806471
[Myoclonus in Alzheimer's disease].
Bogolepova, A. B., Burd, S. G., Lebedeva, A. V., Rubleva, Y., Kovalenko, E. A., Machnovich, E. V., Osinovskaya, N. A., Pantina, N., Kovaleva, I. I., Bokitko, T. A., et al. (2026) · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · doi:10.17116/jnevro202612604263
The Saga of Late-Onset Unexplained Epilepsy
Sarkis, R. A., Johnson, E. L., & Lam, A. D. (2026) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597261454275
Neurodegenerative diseases and myoclonus
Grippe, T. C., Falletti, M., Suppa, A., & Chen, R. (2026) · International review of movement disorders · doi:10.1016/bs.irmvd.2026.06.002
A massively parallel CRISPR-based screening platform for modifiers of neuronal depolarization
Boggess, S. C., Gandhi, V., Tsai, M., Marzette, E., Teyssier, N., Chou, J. Y.-Y., Hu, X., Cramer, A. L., Yadanar, L., Shroff, K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75882-0 · Cited by 8
Vaknalli, R. N., Addo-Osafo, K., Chenchu, V. S. M., Hwang, K., de Vicente, M., Bragin, A., & Vossel, K. A. (2026) · Research Square · doi:10.21203/rs.3.rs-10385398/v1
Self-citationCarpinelli, L., Lins, J. P. S., Velazquez, A. A., Bernardino, J. V. C., Júnior, D. V. D. S. L., Soares, V. H. D., Gauer, L. E., & Brucki, S. M. D. (2026) · Seizure · doi:10.1016/j.seizure.2026.08.014
Human P301L tau expression in mice alters neuronal excitability independent of neurodegeneration
Dunton, K. L., Monchal, H., Achorn, B. E., Mandé‐Niedergang, B., Roucard, C., Roche, Y., Evrard, A., & Menniti, F. S. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1814637
Hyperexcitable but seizure-free: hippocampal network dysfunction in a Wolfram syndrome modelPreprint
Ahmadi, S., Pinera, J. G., Dokholyan, S., Sauerbeck, A. D., Phan, H. N., Carman, B., Debnath, A., Brunwasser, S., Skinner, G., Rensing, N. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.27.754840
Myoclonus in Alzheimer’s Disease
Bogolepova, A. N., Бурд, С. Г., Lebedeva, A. V., Rubleva, Y. V., Kovalenko, E. A., Makhnovich, E. V., Osinovskaya, N. A., Pantina, N. V., Kovaleva, I. I., Bokitko, T. A., et al. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-02075-z
Metadata
- Authors
- Beagle, A. J., Darwish, S. M., Ranasinghe, K. G., La, A. L., Karageorgiou, E., & Vossel, K. A.
- Affiliations
- University of California, San Francisco (US)
- University of Minnesota (US)
- Corresponding author
- Vossel, Keith A.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2017-08-29
- Volume
- 60
- Issue
- 1
- Pages
- 211-223
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5608587
- OpenAlex
- W2746678792
- Cited by
- 173
- References
- 62
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 27 · 2023: 17 · 2022: 17 · 2021: 25 · 2020: 27 · 2019: 10 · 2018: 8
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of California, San Francisco
- National Institute on Aging (K23AG038357, F32AG050434)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, dementia with Lewy bodies
- MeSH terms
- Aged, Alzheimer Disease, Female, Humans, Male, Middle Aged, Myoclonus, Psychiatric Status Rating Scales, Retrospective Studies, Seizures, Severity of Illness Index, Incidence, Age Distribution, Lewy Body Disease, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
